We have all been cheered by the early results of Covid-19 vaccine trials, albeit with accompanying concerns about the distribution and delivery of the candidates to the general public. This will be a huge logistical exercise, and the relevant government departments haven’t covered themselves in glory on logistical matters so far.
But there’s a bigger issue that might well be coming down the line, one that we should consider and discuss before it’s too late.
Let’s start with a few assumptions. First, that whichever vaccines are deployed have a good result. Secondly, let’s assume that supplies are not going to be like running water, and that there will be logistical issues with purchase, supply, distribution and clinical handling, let alone getting people to turn up on time at the right location for…
You're reading a preview of
PC Pro (Digital) - 1 Issue, February 2021